We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

OPY:NYSEOppenheimer Holdings, Inc. Analysis

Data as of 2026-08-23 - not real-time

$115.99

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

At $115.99, Oppenheimer Holdings Inc. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. Momentum indicators put RSI at 55.3 (neutral) with MACD reading bearish. The recent range runs from support at $102.71 up to resistance at $120.70.
Valuation screens as fair: a P/E of 12.9 sits below the sector average of 16.8. Revenue is growing at 24.1% on a 6.0% profit margin. The 0.69% dividend yield looks covered by current payout levels.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 37.4%, a beta of 1.01 and a maximum drawdown of 21.4%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 4 out of 10.

Top Market Events

WKYC323dOppenheimer: Q2 Earnings SnapshotNEW YORK AP — NEW YORK AP — Oppenheimer Holdings Inc.Detailed price information for Oppenheimer Holdings OPY-N from The Globe and Mail including charting and trades.Seeking Alpha22dOppenheimer Holdings: Our Preferred Pick In A Less Preferred SectorBank deposit sweep income is...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 92.00
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 12.9 versus sector average of 16.8
  • Trading above the 200-day average of 92.00

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • P/E of 12.9 versus sector average of 16.8
  • Revenue growth of +24.1%
  • Dividend yield of 0.69%

Key Metrics & Analysis

Financial Health

Revenue Growth24.10%
Profit Margin5.99%
P/E Ratio12.9
ROE10.82%
ROA2.59%
Debt/Equity147.91
P/B Ratio1.3
Op. Cash Flow$-4584000
Industry P/E16.8

Technical Analysis

TrendBullish
RSI55.3
Support$102.71
Resistance$120.70
MA 20$113.45
MA 50$111.37
MA 200$92.00
MACDBearish
VolumeDecreasing
Fear & Greed Index94.41

Valuation

GradeFair
TypeBlend
Dividend Yield0.69%

Risk Assessment

Beta1.01
Volatility37.42%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.